(Q43637785)

25 November 2017

title

The opioid placebo analgesia is mediated exclusively through μ-opioid receptor in rat. (English)

1 reference

25 November 2017

0 references

1 reference

Rui-Rui Zhang

1

1 reference

25 November 2017

Wen-Cai Zhang

series ordinal

2

1 reference

25 November 2017

Jin-Yan Wang

series ordinal

3

1 reference

25 November 2017

Jian-You Guo

series ordinal

4

1 reference

25 November 2017

publication date

25 July 2012

1 reference

The International Journal of Neuropsychopharmacology

25 November 2017

published in

1 reference

25 November 2017

volume

16

1 reference

25 November 2017

issue

4

1 reference

25 November 2017

page(s)

849-856

1 reference

Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712000673

Molecular biology of the opioid receptors: structures, functions and distributions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712000673

Brain activity associated with expectancy-enhanced placebo analgesia as measured by functional magnetic resonance imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712000673

Placebo analgesia affects the behavioral despair tests and hormonal secretions in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712000673

Dissection of placebo analgesia in mice: the conditions for activation of opioid and non-opioid systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712000673

Placebo and naloxone can alter post-surgical pain by separate mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712000673

Mice deficient for delta- and mu-opioid receptors exhibit opposing alterations of emotional responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712000673

Activation of the opioidergic descending pain control system underlies placebo analgesia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712000673

Blockade of endogenous opioid neurotransmission enhances acquisition of conditioned fear in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712000673

The dynamic mechanisms of placebo induced analgesia: Evidence of sustained and transient regional involvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712000673

How the number of learning trials affects placebo and nocebo responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712000673

Placebo analgesia induced by social observational learning

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712000673

Placebo analgesia and beyond: a melting pot of concepts and ideas for neuroscience

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712000673

Differential effects of systemically administered nor-binaltorphimine (nor-BNI) on kappa-opioid agonists in the mouse writhing assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712000673

Regulation of Human Affective Responses by Anterior Cingulate and Limbic µ-Opioid Neurotransmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712000673

Placebo effects mediated by endogenous opioid activity on mu-opioid receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712000673

Rostral anterior cingulate cortex volume correlates with depressed mood in normal healthy children

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712000673

Placebo effects on human mu-opioid activity during pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712000673

Mechanisms of placebo analgesia: rACC recruitment of a subcortical antinociceptive network.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712000673

Placebo-induced changes in FMRI in the anticipation and experience of pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712000673

Synapse regression in depression: the role of 5-HT receptors in modulating NMDA receptor function and synaptic plasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712000673

Opioid-mediated placebo responses boost pain endurance and physical performance: is it doping in sport competitions?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712000673

Neurobiological mechanisms of the placebo effect.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712000673

Placebo and nocebo effects are defined by opposite opioid and dopaminergic responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712000673

Disruption of opioid-induced placebo responses by activation of cholecystokinin type-2 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712000673

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712000673

The neurobiology of placebo analgesia: from endogenous opioids to cholecystokinin

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712000673

Brain mechanisms of expectation associated with insula and amygdala response to aversive taste: implications for placebo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712000673

The opposite effects of the opiate antagonist naloxone and the cholecystokinin antagonist proglumide on placebo analgesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712000673

Endothelin-A receptor antagonism attenuates carcinoma-induced pain through opioids in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712000673

Neuroimaging study of placebo analgesia in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712000673

A comprehensive review of the placebo effect: recent advances and current thought

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712000673

Frontocingulate dysfunction in depression: toward biomarkers of treatment response

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712000673

Placebo and opioid analgesia-- imaging a shared neuronal network

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712000673

Deficit in attachment behavior in mice lacking the mu-opioid receptor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712000673

The mechanism of placebo analgesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712000673

inferred from DOI database lookup

7 January 2021

based on heuristic

Pharmacological selectivity of CTAP in a warm water tail-withdrawal antinociception assay in rats

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712000673

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1017/S1461145712000673

1 reference

25 November 2017

1 reference